Iowa State Bank lowered its stake in shares of Chemed Co. (NYSE:CHE) by 10.0% during the fourth quarter, HoldingsChannel reports. The firm owned 1,900 shares of the company’s stock after selling 210 shares during the quarter. Iowa State Bank’s holdings in Chemed were worth $462,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. IFP Advisors Inc raised its stake in shares of Chemed by 1,504.5% during the 3rd quarter. IFP Advisors Inc now owns 706 shares of the company’s stock worth $143,000 after purchasing an additional 662 shares in the last quarter. MCF Advisors LLC bought a new stake in Chemed in the 3rd quarter valued at $152,000. Hengehold Capital Management LLC bought a new stake in Chemed in the 4th quarter valued at $203,000. Magnetar Financial LLC bought a new stake in Chemed in the 3rd quarter valued at $207,000. Finally, LS Investment Advisors LLC raised its stake in Chemed by 60.7% in the 4th quarter. LS Investment Advisors LLC now owns 937 shares of the company’s stock valued at $228,000 after acquiring an additional 354 shares during the period. Institutional investors own 97.04% of the company’s stock.

Shares of Chemed Co. (NYSE:CHE) opened at $253.43 on Monday. Chemed Co. has a 12 month low of $167.97 and a 12 month high of $275.83. The company has a quick ratio of 0.48, a current ratio of 0.50 and a debt-to-equity ratio of 0.15. The firm has a market capitalization of $4,046.26, a price-to-earnings ratio of 56.32 and a beta of 1.13.

A number of equities research analysts recently weighed in on CHE shares. Royal Bank of Canada increased their price target on Chemed to $232.00 and gave the company a “sector perform” rating in a research note on Tuesday, October 31st. KeyCorp restated a “hold” rating on shares of Chemed in a research note on Friday, October 27th. TheStreet upgraded Chemed from a “c+” rating to an “a-” rating in a research note on Friday, October 27th. Zacks Investment Research upgraded Chemed from a “hold” rating to a “buy” rating and set a $251.00 price target on the stock in a research note on Thursday, November 2nd. Finally, ValuEngine cut Chemed from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Four analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $236.00.

In other Chemed news, insider Spencer S. Lee sold 1,000 shares of the stock in a transaction on Wednesday, November 15th. The stock was sold at an average price of $232.27, for a total transaction of $232,270.00. Following the transaction, the insider now owns 35,809 shares in the company, valued at approximately $8,317,356.43. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Michael D. Witzeman sold 1,579 shares of the stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $235.00, for a total value of $371,065.00. Following the transaction, the vice president now owns 4,334 shares in the company, valued at approximately $1,018,490. The disclosure for this sale can be found here. In the last 90 days, insiders sold 21,529 shares of company stock worth $5,136,966. 4.90% of the stock is owned by company insiders.

COPYRIGHT VIOLATION NOTICE: This story was posted by Watch List News and is the property of of Watch List News. If you are reading this story on another website, it was illegally copied and republished in violation of US and international copyright and trademark laws. The original version of this story can be accessed at https://www.watchlistnews.com/iowa-state-bank-has-462000-stake-in-chemed-co-che/1861585.html.

Chemed Company Profile

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.